A systematic review reveals that GLP-1 receptor agonists not only address psychotropic-induced metabolic disorders but also may positively impact mental wellbeing.
In the SURMOUNT-5 trial, tirzepatide led to a 20.2% mean weight loss in adults with obesity—significantly more than the 13.7% achieved with semaglutide.
A minimally invasive procedure using electrical pulses in the small intestine shows promise in significantly improving type 2 diabetes, with benefits rivaling gastric bypass surgery.
From new sustainable education initiatives to cardiovascular health and AMD links, these are the news stories and studies that caught our attention this week…
Researchers linked di-2-ethylhexylphthalate plastic exposure to over 350,000 cardiovascular deaths and 10 million years of life lost, supporting calls for international regulatory measures.